Pancreatic Cancer Research

ResearcherNantong UniversityActive in the last 2 years

Chunbin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-0433-7020; OpenAlex author ID A5026794479. Sources: OpenAlex.

Their work

Papers
5 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 3 papers · 2026: 1 paper

Papers 5

  1. Autophagy Inhibition Enhances the Antitumor Efficacy of MET Targeting in MET-High Pancreatic Cancer. First author DOI 10.32604/or.2026.084396↗
  2. Autophagy-targeted intervention synergized with pegaspargase: an innovative therapeutic paradigm for pancreatic cancer. Last author DOI 10.1186/s12935-025-04074-5↗
  3. Development and validation of an MBD3/UHRF1 methylation-regulator-based prognostic model for pancreatic cancer survival. Co-author DOI 10.21037/tcr-24-1887↗
  4. A novel and promising therapeutic approach for treating pancreatic cancer: Nectin‑4‑targeted antibody‑drug conjugates alone or combined with autophagy inhibito… First author DOI 10.3892/ijmm.2025.5507↗
  5. Improvement of Diagnostic Accuracy for Pancreatic Cancer with Serum Lactate Dehydrogenase. First author DOI 10.2147/cmar.s312312↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuyao Zhang · 3 shared papers, 2025–2026 · strength 0.85
  2. Dandan Zhou · 2 shared papers, 2025–2026 · strength 0.60
  3. Zhe Ding · 2 shared papers, 2025 · strength 0.54
  4. Xue Cheng · 1 shared paper, 2025 · strength 0.37
  5. Kai Chen · 1 shared paper, 2025 · strength 0.37
  6. Zhiyi Min · 1 shared paper, 2026 · strength 0.32
  7. Zhe Ding · 1 shared paper, 2026 · strength 0.32
  8. Rong Fu · 1 shared paper, 2025 · strength 0.26
  9. Xi Wang · 1 shared paper, 2021 · strength 0.22
  10. Haijun Zhang · 1 shared paper, 2021 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.